MedTrace Logo

Urinary Tract Infection Due to Beta-lactamase-producing Enterobacteriaceae in Children

NCT02832258 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 590

Last updated 2020-08-04

No results posted yet for this study

Summary

Urinary tract infection due to Extended-spectrum beta-lactamase producing enterobacteriaceae (E-ESBL UTI) become a frequent problem. A too large variety in the prescription of antibiotics for E-ESBL UTI in children and absolute recommendations regarding the optimal treatment of E-ESBL is nearly impossible at this time.

Our aim was to describe the characteristics and treatments of urinary tract infections caused by Extended spectrum betalactamase-producing Enterobacteriaceae in children.

Conditions

Sponsors & Collaborators

  • Fouad Madhi

    lead OTHER

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2019-03-27
Completion
2019-06-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02832258 on ClinicalTrials.gov